176 related articles for article (PubMed ID: 3841726)
1. Graves' disease with neutropenia and marked splenomegaly: autoimmune neutropenia due to propylthiouracil.
Sato K; Miyakawa M; Han DC; Kato S; Shibagaki Y; Tsushima T; Shizume K
J Endocrinol Invest; 1985 Dec; 8(6):551-5. PubMed ID: 3841726
[TBL] [Abstract][Full Text] [Related]
2. [Presentation of a case of Graves' disease with neutropenia and splenomegaly: propylthiouracil-induced autoimmune neutropenia and review of the literature on the drug-induced lupus-like syndrome].
Miyakawa M; Sato K; Sato Y; Tsushima T; Shizume K; Inoue T
Nihon Naika Gakkai Zasshi; 1984 Apr; 73(4):538-45. PubMed ID: 6547974
[No Abstract] [Full Text] [Related]
3. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
[TBL] [Abstract][Full Text] [Related]
4. Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy.
Finucane FM; O'Connell J; Kinsley BT
Ir J Med Sci; 2008 Mar; 177(1):69-71. PubMed ID: 17611791
[TBL] [Abstract][Full Text] [Related]
5. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
[TBL] [Abstract][Full Text] [Related]
6. Propylthiouracil-induced agranulocytosis as a rare complication of antithyroid drugs in a patient with Graves' disease.
Rabelo PN; Rabelo PN; Paula AF; Conceição SAD; Viggiano DPPO; Antunes DE; Jatene EM; Paula SLFM; Dias ML; Reis MAL
Rev Assoc Med Bras (1992); 2019 Jul; 65(6):755-760. PubMed ID: 31340298
[TBL] [Abstract][Full Text] [Related]
7. Propylthiouracil-induced anti-neutrophil cytoplasmic antibodies and agranulocytosis together with granulocyte colony-stimulating factor induced Sweet's syndrome in a patient with Graves' disease.
Ozlem C; Deram B; Mustafa S; Koray T; Cuyan D; Ertugrul T
Intern Med; 2011; 50(18):1973-6. PubMed ID: 21921379
[TBL] [Abstract][Full Text] [Related]
8. Propylthiouracil (PTU)-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).
Balkin MS; Buchholtz M; Ortiz J; Green AJ
Thyroid; 1993; 3(4):305-9. PubMed ID: 7509672
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity.
Akamizu T; Ozaki S; Hiratani H; Uesugi H; Sobajima J; Hataya Y; Kanamoto N; Saijo M; Hattori Y; Moriyama K; Ohmori K; Nakao K
Clin Exp Immunol; 2002 Jan; 127(1):92-8. PubMed ID: 11882038
[TBL] [Abstract][Full Text] [Related]
10. An anti-neutrophil antibody associated with a propylthiouracil-induced lupus-like syndrome.
Berkman EM; Orlin JB; Wolfsdorf J
Transfusion; 1983; 23(2):135-8. PubMed ID: 6836692
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
14. Lupus-like syndrome--a rare complication in thionamide treatment for Graves' disease.
Takuwa N; Kojima I; Ogata E
Endocrinol Jpn; 1981 Oct; 28(5):663-7. PubMed ID: 6896490
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil.
Cin MO; Gursoy A; Morris Y; Aydintug OT; Kamel N; Gullu S
Int J Clin Pract; 2009 Feb; 63(2):299-302. PubMed ID: 19196368
[TBL] [Abstract][Full Text] [Related]
16. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
[TBL] [Abstract][Full Text] [Related]
17. Propylthiouracil induced ANCA-associated vasculitis in a 14-year-old girl.
Schamp V; Verfaillie C; Bonroy C; Vande Walle J; Raes A; Dehoorne J
Acta Clin Belg; 2015 Apr; 70(2):127-9. PubMed ID: 25937486
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
[TBL] [Abstract][Full Text] [Related]
19. Management of a pregnant patient with Graves' disease complicated by thionamide-induced neutropenia in the first trimester.
Davison S; Lennard TW; Davison J; Kendall-Taylor P; Perros P
Clin Endocrinol (Oxf); 2001 Apr; 54(4):559-61. PubMed ID: 11318795
[TBL] [Abstract][Full Text] [Related]
20. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
